己糖激酶 (HK) 在细胞葡萄糖代谢中起着核心作用。己糖激酶催化葡萄糖代谢的第一步,即 ATP 依赖性葡萄糖 (Glc) 磷酸化,生成葡萄糖-6-磷酸 (Glc-6-P)。除了维持允许葡萄糖进入细胞的下坡浓度梯度外,该反应还构成了所有主要葡萄糖利用途径的第一步,包括糖酵解、戊糖磷酸途径 (PPP) 和糖原生成。因此,己糖激酶具有独特的优势,可以影响细胞内葡萄糖通量的程度和方向。PPP 代表 NADPH 的主要细胞来源,在氧化还原稳态、合成代谢和核苷酸合成(Rib-5-P,核酮糖 5-磷酸)中发挥重要作用。同样,糖酵解和糖原生成分别在能量代谢和储存中发挥重要作用。其他重要的细胞功能,包括糖胺聚糖和糖蛋白生物合成所需的己糖胺和核苷酸糖生成,也需要 Glc-6-P 作为前体(UDP-Glc,尿苷二磷酸葡萄糖;UDP-GlcNAc,尿苷二磷酸 N-乙酰葡萄糖胺)。
Hexokinases (HK) play a central role in cellular glucose metabolism. Hexokinasescatalyse the first obligatory step of glucose metabolism, the ATP-dependent phosphorylation of glucose (Glc) to yield glucose-6-phosphate (Glc-6-P). In addition to maintaining the downhill concentration gradient that permits facilitated glucose entry into cells, this reaction constitutes the first step of all major pathways of glucose utilization, including glycolysis, the pentose phosphate pathway, (PPP) and glycogenesis. As such hexokinases are uniquely positioned to influence the extent and direction of glucose flux within the cell. The PPP represents the principal cellular source of NADPH and plays important roles in redox homeostasis, anabolism and nucleotide synthesis (Rib-5-P, ribulose 5-phosphate). Similarly, glycolysis and glycogenesis play important roles in energy metabolism and storage, respectively. Other important cellular functions, including hexosamine and nucleotide sugar generation for glycosaminoglycan and glycoprotein biosynthesis, also require Glc-6-P as a precursor (UDP-Glc, uridine diphosphate glucose; UDP-GlcNAc, uridine diphosphate N-acetylglucosamine).
PROTAC HK2 Degrader-1 是一种靶向 Hexokinase 2 (HK2) 的 PROTAC,由 Hexokinase 2 (HK2) 抑制剂 Lonidamine (MS-N14681) 与 CRBN 配体 Thalidomide (MS-B42308) 组成,通过泛素-蛋白酶体系统形成三元复合体降解 Hexokinase 2 (HK2) 蛋白,诱导线粒体损伤并引发细胞焦亡 (pyroptosis),能有效抑制乳腺肿瘤生长并减少 Cisplatin (MS-E94993) 的结肠副作用,可用于乳腺癌的研究(粉色:Hexokinase 2 配体 (MS-N14681);蓝色:Cereblon 配体 (MS-N78428);黑色:连接子 (MS-Y19507))。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号